Clinical Trials Sponsored by Chugai Pharmaceutical

Total 19638 results

Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

Postmenopausal Women With Advanced Breast Cancer

Japan
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment

Postmenopausal Women With Advanced Breast Cancer

Japan
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

Postmenopausal Women With Advanced Breast Cancer

Japan
Chugai Pharmaceutical

Recruiting

Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients

Celiac Disease

United States, Australia
Chugai Pharmaceutical

Completed

A Phase 2 Study of CIM331 for Atopic Dermatitis Patients

Atopic Dermatitis

United States
Chugai Pharmaceutical

Completed

Excretion Balance, PK and Metabolism of a Single Oral Dose of [14C]PCO371

Healthy Volunteers

United Kingdom
Chugai Pharmaceutical

Completed

A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis

Hyperphosphatemia

United States
Chugai Pharmaceutical

Terminated

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics/Pharmacodynamics (PK/PD) of Ocrelizumab in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Chugai Pharmaceutical

Completed

A Multiple-dose Study of Gantenerumab in Japanese Alzheimer&Apos;s Disease Patients

Alzheimer's Disease

Japan
Chugai Pharmaceutical

Completed

Trial of Pegasys® in Patients With Chronic Hepatitis C

Chronic Hepatitis C

Japan
Chugai Pharmaceutical

Completed

PhaseⅢOpen-label Study of MRA for Rheumatoid Arthritis(RA)

Rheumatoid Arthritis

Japan
Chugai Pharmaceutical

Completed

Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA)

Rheumatoid Arthritis
Chugai Pharmaceutical

Completed

Clinical Study of R744 to Hemodialysis Patients

Hemodialysis Patients

Japan
Chugai Pharmaceutical

Recruiting

A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors

Solid Tumor

United States, Japan
Chugai Pharmaceutical

Completed

A Decentralized Home-Based Study To Investigate Novel Objective Biomarker Of Gluten-Mediated Symptoms In Celiac Disease Participants (CeDar ROSE Study)

Celiac Disease

United States
Chugai Pharmaceutical

Terminated

A Clinical Study Investigating the Safety, Tolerability, PK and PD of PCO371 in Patients With Hypoparathyroidism

Hypoparathyroidism

United States, Canada, Hungary
Chugai Pharmaceutical

Completed

Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA012JP

Rheumatoid Arthritis
Chugai Pharmaceutical

Completed

Study of MRA in Patients With Rheumatoid Arthritis (RA)

Rheumatoid Arthritis
Chugai Pharmaceutical

Completed

A New Active Vitamin D, ED-71 for Osteoporosis

Osteoporosis
Chugai Pharmaceutical

Completed

A Phase I Study of GC33 in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)

Advanced or Metastatic HCC

United States
Chugai Pharmaceutical

Completed

A Study of Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With MRA(a Development Code of Tocilizumab, an Anti IL-6 Receptor Monoclonal Antibody.)

Rheumatoid Arthritis

Japan
Chugai Pharmaceutical

Completed

Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast Cancer

Metastatic Breast Cancer

Japan
Chugai Pharmaceutical

Completed

A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC)

Liver Cirrhosis | Chronic Hepatitis C

Japan
Chugai Pharmaceutical

Completed

Long-term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)

Polyarticular Juvenile Idiopathic Arthritis
Chugai Pharmaceutical

Completed

Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)

Systemic Juvenile Idiopathic Arthritis
Chugai Pharmaceutical

Completed

Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA213JP

Rheumatoid Arthritis
Chugai Pharmaceutical

Completed

Drug-Drug Interaction Study of MRA in Patient With Rheumatoid Arthritis (RA)

Rheumatoid Arthritis
Chugai Pharmaceutical

Completed

Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)

Systemic Juvenile Idiopathic Arthritis
Chugai Pharmaceutical

Completed

Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)

Systemic Juvenile Idiopathic Arthritis
Chugai Pharmaceutical

Not yet recruiting

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

Antiphospholipid Syndrome (APS) | Immune Thrombocytopenia (ITP) | Dermatomyositis (DM) | Bullous Pemphigoid (BP) | Behçet's Syndrome (BS) | Immune-mediated Necrotizing Myopathy (IMNM)

United States, Japan
Chugai Pharmaceutical

Recruiting

A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors

Solid Tumor

United States, Japan
Chugai Pharmaceutical

Not yet recruiting

Post-Marketing Drug Intensive Monitoring Surveillance of EDIROL in Patients With Postmenopausal Osteoporosis

Postmenopausal Osteoporosis

China
Chugai Pharmaceutical

Recruiting

A Phase I Study of ERY974 in Patients With Hepatocellular Carcinoma

Hepatocellular Carcinoma (HCC)

Taiwan, Japan
Chugai Pharmaceutical

Recruiting

A Dose-escalation Study of LUNA18 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).

Locally Advanced or Metastatic Solid Tumors

United States, Japan
Chugai Pharmaceutical

Recruiting

A Dose-Escalation Study of SPYK04 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).

Locally Advanced or Metastatic Solid Tumors

United States, Japan
Chugai Pharmaceutical

Completed

A Clinical Pharmacology Study to Evaluate the Effect of GYM329 on Disuse Muscle Atrophy in Healthy Volunteer

Healthy Volunteers

Netherlands
Chugai Pharmaceutical

Completed

PD-L1 Expression in Japanese Renal Cell Carcinoma Patients

Renal Cell Carcinoma

Japan
Chugai Pharmaceutical

Unknown

CAPOXIRI+Bevacizumab vs. FOLFOXIRI+Bevacizumab for mCRC (QUATTRO-II)

Metastatic Colorectal Cancer

Japan
Chugai Pharmaceutical

Completed

A Study of ERY974 in Patient With Advanced Solid Tumors

Solid Tumors

United States, France, Netherlands
Chugai Pharmaceutical

Completed

Non-drug Study to Assess the Suitability of Assessment Scales in Japanese Individuals With Down Syndrome Aged 6-30

Down Syndrome

Japan
Chugai Pharmaceutical

Terminated

A Single Ascending Dose Study of PCO371 in Healthy Volunteers

Healthy

United States
Chugai Pharmaceutical

Completed

Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA220JP or MRA221JP

Rheumatoid Arthritis
Chugai Pharmaceutical

Completed

Phase II/III Clinical Study of R484iv (Ibandronic Acid) for Primary Osteoporosis

Primary Osteoporosis

Japan
Chugai Pharmaceutical

Completed

Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) Patients

Anemia

Japan
Chugai Pharmaceutical

Completed

Correction Study of R744 in Renal Anemia Patients on Hemodialysis

Hemodialysis Patients

Japan
Chugai Pharmaceutical

Completed

A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

Chemotherapy Induced Anemia
Chugai Pharmaceutical

Completed

Clinical Study of R744 to Peritoneal Dialysis Patients

Peritoneal Dialysis Patients

Japan
Chugai Pharmaceutical

Completed

Clinical Study of R744 to Predialysis Patients

Anemia in Pre-Dialysis Patients

Japan
Chugai Pharmaceutical

Completed

A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Patients With Chronic Hepatitis C

Chronic Hepatitis C
Chugai Pharmaceutical

Completed

A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

Chemotherapy Induced Anemia

3

Subscribe